DOBUTamine (Hospira, Inc.)
Welcome to the PulseAid listing for the DOBUTamine drug offered from Hospira, Inc.. This Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | DOBUTAMINE HYDROCHLORIDE |
| SUBSTANCE NAME: | DOBUTAMINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2005-11-17 |
| END MARKETING DATE: | 0000-00-00 |
DOBUTamine HUMAN PRESCRIPTION DRUG Details:
| Item Description | DOBUTamine from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12.5(mg/mL) |
| START MARKETING DATE: | 2005-11-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0409-2025_2a5bc36a-2778-42de-844b-9e9c5e218075 |
| PRODUCT NDC: | 0409-2025 |
| APPLICATION NUMBER: | ANDA074292 |
Other DOBUTAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
